Roche’s Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study: Basel Wednesday, December 10, 2025, 18:00 Hrs [IST] Roch ...
India to co-host 2nd WHO Global Summit on Traditional Medicine in New Delhi: Our Bureau, New Delhi Wednesday, December 10, 2025, 16:45 Hrs [IST] Union Ministry of Ayush has announ ...
Abbott announces Lingo, an OTC continuous glucose monitor and app, now available on Android devices: Abbott Park, Illinois Wednesday, December 10, 2025, 17:00 Hrs [IST] Abbott ann ...
Atypical Parkinsonism, a collection of neurodegenerative diseases that share symptoms with Parkinson's Disease but have unique features, poses challenges for patients and healthcare providers. They ...
EpiVax and US FDA scientists publish new insights on immunogenicity risks of peptide-related impurities in generic teriparatide: Providence, Rhode Island Wednesday, December 10, 2 ...
Kiran Mazumdar-Shaw honoured with ‘USC Business Management Award’ for her contributions in global healthcare and biotechnology: Our Bureau, Bengaluru Wednesday, December 10, 2 ...
Zydus and Formycon partner for licensing and supply of biosimilar to Keytruda in US and Canada: Our Bureau, Mumbai Wednesday, December 10, 2025, 15:20 Hrs [IST] Zydus Lifesciences ...
Roche introduces new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark: Basel Wednesday, December 10, 2025, 15:00 Hrs ...
Consistently high efficacy was seen across subgroups with ORR of 96%-100% and three-year ongoing response rates of 60%-83%, including in patients with high-risk characteristics (progression of disease ...
Ceiling Price fixation or revision resulted in annual savings of Rs. 3,800 crore, says minister: Our Bureau, New Delhi Wednesday, December 10, 2025, 15:30 Hrs [IST] The National P ...
Japan’s MHLW grants Pioneering Regenerative Medical Product Designation to AskBio’s AB-1005 and AB-1002: Berlin, Germany Wednesday, December 10, 2025, 12:00 Hrs [IST] AskBio I ...
US FDA approves Gamida Cell’s Omisirge, first cellular therapy to treat patients with severe aplastic anaemia: Silver Spring, Maryland Wednesday, December 10, 2025, 11:00 Hrs [I ...